相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exploring a peptide nucleic acid-based antisense approach for CD5 targeting in chronic lymphocytic leukemia
Elena Cesaro et al.
PLOS ONE (2022)
Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures
Michael Hallek et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
The extracellular matrix: A key player in the pathogenesis of hematologic malignancies
Ishnoor Sidhu et al.
BLOOD REVIEWS (2021)
ZNF224 Protein: Multifaceted Functions Based on Its Molecular Partners
Elena Cesaro et al.
MOLECULES (2021)
KRAB-ZFP Transcriptional Regulators Acting as Oncogenes and Tumor Suppressors: An Overview
Joanna Sobocinska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Oxidative Stress and ROS-Mediated Signaling in Leukemia: Novel Promising Perspectives to Eradicate Chemoresistant Cells in Myeloid Leukemia
Silvia Trombetti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
ZNF224 is a mediator of TGF-β pro-oncogenic function in melanoma
Elena Cesaro et al.
HUMAN MOLECULAR GENETICS (2021)
High Bax/Bcl-2 ratio is associated with good prognosis and better survival in patients with B cell chronic lymphocytic leukemia
Nesrine A. Helaly et al.
LEUKEMIA RESEARCH (2021)
Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies
Julio Delgado et al.
HAEMATOLOGICA (2020)
Treatment of Chronic Lymphocytic Leukemia
Jan A. Burger
NEW ENGLAND JOURNAL OF MEDICINE (2020)
3D culture enhances chemoresistance of ALL Jurkat cell line by increasing DDR1 expression
Jun Guo et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
NOX2-Dependent Reactive Oxygen Species Regulate Formyl-Peptide Receptor 1-Mediated TrkA Transactivation in SH-SY5Y Cells
Martina Castaldo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Prognostic significance of aberrant CD5 expression in B-cell leukemia
Kaveh Jaseb et al.
ONCOLOGY REVIEWS (2019)
Role of ZNF224 in c-Myc repression and imatinib responsiveness in chronic myeloid leukemia
Gaetano Sodaro et al.
ONCOTARGET (2018)
ZNF224 is a transcriptional repressor of AXL in chronic myeloid leukemia cells
Gaetano Sodaro et al.
BIOCHIMIE (2018)
Role of ZNF224 in cell growth and chemoresistance of chronic lymphocitic leukemia
Teresa Busiello et al.
HUMAN MOLECULAR GENETICS (2017)
Predictive and prognostic biomarkers in the era of new targeted therapies for chronic lymphocytic leukemia
Davide Rossi et al.
LEUKEMIA & LYMPHOMA (2017)
Lin28 is induced in primed embryonic stem cells and regulates let-7-independent events
Silvia Parisi et al.
FASEB JOURNAL (2017)
Heterogeneous expression of the collagen receptor DDR1 in chronic lymphocytic leukaemia and correlation with progression
G. Barisione et al.
BLOOD CANCER JOURNAL (2017)
Chronic lymphocytic leukaemia
Thomas J. Kipps et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia
Maria Ilaria Del Principe et al.
HAEMATOLOGICA (2016)
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia
Maria Ilaria Del Principe et al.
HAEMATOLOGICA (2016)
B-cell survival and development controlled by the coordination of NF-κB family members RelB and cRel
Jonathan V. Almaden et al.
BLOOD (2016)
Chronic lymphocytic leukaemia
Lydia Scarfo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions
Larry Mansouri et al.
SEMINARS IN CANCER BIOLOGY (2016)
Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification
Paolo Strati et al.
BLOOD (2015)
WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene
Giorgia Montano et al.
ONCOTARGET (2015)
Function of phosphorylation of NF-kB p65 ser536 in prostate cancer oncogenesis
Li Zhang et al.
ONCOTARGET (2015)
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia
Kami J. Maddocks et al.
JAMA ONCOLOGY (2015)
Serum deprivation elevates the levels of microvesicles with different size distributions and selectively enriched proteins in human myeloma cells in vitro
Li Sun et al.
ACTA PHARMACOLOGICA SINICA (2014)
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2014)
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study
Panagiotis Baliakas et al.
LANCET HAEMATOLOGY (2014)
The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1
Fathima Zumla Cader et al.
BLOOD (2013)
Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression
Han-Yu Chuang et al.
BLOOD (2012)
Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in CLL
Claudia Philipp et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus
Lukas P. Frenzel et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
CD5 Promotes IL-10 Production in Chronic Lymphocytic Leukemia B Cells through STAT3 and NFAT2 Activation
Soizic Garaud et al.
JOURNAL OF IMMUNOLOGY (2011)
An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia
T. Herold et al.
LEUKEMIA (2011)
Rituximab regulates signaling pathways and alters gene expression associated with cell death and survival in diffuse large B-cell lymphoma
Satu Koivula et al.
ONCOLOGY REPORTS (2011)
Using the Biology of Chronic Lymphocytic Leukemia to Choose Treatment
Peter Hillmen
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2011)
Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia
Tom Butler et al.
BLOOD REVIEWS (2010)
Cell-Permeable Peptide DEPDC1-ZNF224 Interferes with Transcriptional Repression and Oncogenicity in Bladder Cancer Cells
Yosuke Harada et al.
CANCER RESEARCH (2010)
NF-kappa B as a therapeutic target in chronic lymphocytic leukemia
Monica Lopez-Guerra et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations
T. Zenz et al.
LEUKEMIA (2010)
Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity
Mahmoud Mansouri et al.
LEUKEMIA RESEARCH (2010)
The IKK Complex, a Central Regulator of NF-kappa B Activation
Alain Israel
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia
Marco Herling et al.
BLOOD (2009)
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
Chris Pepper et al.
BLOOD (2008)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
The effect of FK506 on transforming growth factor β signaling and apaptosis in chronic lymphocytic leukemia B cells
Simona Romano et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia
Rebekah L. Browning et al.
LEUKEMIA RESEARCH (2007)
Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia
Femke Van Bockstaele et al.
CLINICAL CHEMISTRY (2007)
BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-κB pathway
Tomoyuki Endo et al.
BLOOD (2007)
EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX
T Grimm et al.
BLOOD (2005)
Mechanisms of disease: Chronic lymphocytic leukemia
N Chiorazzi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL
TD Shanafelt et al.
BLOOD (2004)
ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia
M Crespo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer
SD Catz et al.
ONCOGENE (2001)
Modulation of NF-κB activity and apoptosis in chronic lymphocytic leukemia B cells
RR Furman et al.
JOURNAL OF IMMUNOLOGY (2000)
Expression of bcl-2 and bax in cells isolated from B-chronic lymphocytic leukemia patients at different stages of the disease
A Aviram et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2000)
分享论文
